177 related articles for article (PubMed ID: 27863412)
1. Associations between XRCC2 rs3218536 and ERCC2 rs13181 polymorphisms and ovarian cancer.
Zhang W; Zhang Z
Oncotarget; 2016 Dec; 7(52):86621-86629. PubMed ID: 27863412
[TBL] [Abstract][Full Text] [Related]
2. ERCC2 Lys751Gln rs13181 and XRCC2 Arg188His rs3218536 Gene Polymorphisms Contribute to Subsceptibility of Colon, Gastric, HCC, Lung And Prostate Cancer.
Balkan E; Bilici M; Gundogdu B; Aksungur N; Kara A; Yasar E; Dogan H; Ozturk G
J BUON; 2020; 25(1):574-581. PubMed ID: 32277685
[TBL] [Abstract][Full Text] [Related]
3. Association of XRCC2 rs3218536 Polymorphism with Susceptibility of Breast and Ovarian Cancer: A Systematic Review and Meta-Analysis.
Kamali M; Hamadani S; Neamatzadeh H; Mazaheri M; Zare Shehneh M; Modaress Gilani M; Haghighi F
Asian Pac J Cancer Prev; 2017 Jul; 18(7):1743-1749. PubMed ID: 28749098
[TBL] [Abstract][Full Text] [Related]
4. Association between the ERCC2 rs13181 polymorphism and the risk of glioma: a meta-analysis.
Jia TL; Wu HJ; Wang HB; Ma WB; Xing B
Genet Mol Res; 2015 Oct; 14(4):12577-84. PubMed ID: 26505408
[TBL] [Abstract][Full Text] [Related]
5. The effect of RAD51 135 G>C and XRCC2 G>A (rs3218536) polymorphisms on ovarian cancer risk among Caucasians: a meta-analysis.
Shi S; Qin L; Tian M; Xie M; Li X; Qi C; Yi X
Tumour Biol; 2014 Jun; 35(6):5797-804. PubMed ID: 24599673
[TBL] [Abstract][Full Text] [Related]
6. Association between ERCC2 rs13181 polymorphism and ovarian cancer risk: an updated meta-analysis with 4024 subjects.
Li J; Pan L; Qin X; Chu H; Mu H; Wan G
Arch Gynecol Obstet; 2017 Sep; 296(3):551-558. PubMed ID: 28676967
[TBL] [Abstract][Full Text] [Related]
7. Association Studies of ERCC2 rs13181 Polymorphism with Pancreatic Cancer Susceptibility.
Shao T; Kou J
Crit Rev Eukaryot Gene Expr; 2021; 31(2):17-23. PubMed ID: 34347976
[TBL] [Abstract][Full Text] [Related]
8. Role of DNA repair and cell cycle control genes in ovarian cancer susceptibility.
Mohamed FZ; Hussien YM; AlBakry MM; Mohamed RH; Said NM
Mol Biol Rep; 2013 May; 40(5):3757-68. PubMed ID: 23277402
[TBL] [Abstract][Full Text] [Related]
9. Association between ERCC2 polymorphisms and glioma risk: a meta-analysis.
Huang LM; Shi X; Yan DF; Zheng M; Deng YJ; Zeng WC; Liu C; Lin XD
Asian Pac J Cancer Prev; 2014; 15(11):4417-22. PubMed ID: 24969862
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the association between the XRCC2 rs3218536 polymorphism and ovarian cancer risk.
Yuan C; Liu X; Li R; Yan S; Kong B
Arch Med Sci; 2020; 16(3):682-691. PubMed ID: 32399118
[TBL] [Abstract][Full Text] [Related]
11. Association between common polymorphisms in ERCC gene and glioma risk: A meta-analysis of 15 studies.
Qian T; Zhang B; Qian C; He Y; Li Y
Medicine (Baltimore); 2017 May; 96(20):e6832. PubMed ID: 28514298
[TBL] [Abstract][Full Text] [Related]
12. ERCC2 polymorphisms and radiation-induced adverse effects on normal tissue: systematic review with meta-analysis and trial sequential analysis.
Song YZ; Duan MN; Zhang YY; Shi WY; Xia CC; Dong LH
Radiat Oncol; 2015 Dec; 10():247. PubMed ID: 26627042
[TBL] [Abstract][Full Text] [Related]
13. Association between ERCC1 C8092A and ERCC2 K751Q polymorphisms and risk of adult glioma: a meta-analysis.
Xu Z; Ma W; Gao L; Xing B
Tumour Biol; 2014 Apr; 35(4):3211-21. PubMed ID: 24254311
[TBL] [Abstract][Full Text] [Related]
14. Association between polymorphisms in ERCC2 gene and oral cancer risk: evidence from a meta-analysis.
Zhang E; Cui Z; Xu Z; Duan W; Huang S; Tan X; Yin Z; Sun C; Lu L
BMC Cancer; 2013 Dec; 13():594. PubMed ID: 24330540
[TBL] [Abstract][Full Text] [Related]
15. Systematic review on the association between ERCC1 rs3212986 and ERCC2 rs13181 polymorphisms and glioma risk.
Zhou CX; Zhao JH
Genet Mol Res; 2015 Mar; 14(1):2868-75. PubMed ID: 25867436
[TBL] [Abstract][Full Text] [Related]
16. Association of R156R single nucleotide polymorphism of the ERCC2 gene with the susceptibility to ovarian cancer.
Romanowicz H; Michalska MM; Samulak D; Malinowski J; Szaflik T; Bieńkiewicz J; Smolarz B
Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():36-40. PubMed ID: 27888704
[TBL] [Abstract][Full Text] [Related]
17. Role of ERCC2 and ERCC3 gene polymorphisms in the development of osteosarcoma.
Ma X; Zhang Y; Sun TS; Yao JH
Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27051024
[TBL] [Abstract][Full Text] [Related]
18. The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility.
Zhao Z; Zhang A; Zhao Y; Xiang J; Yu D; Liang Z; Xu C; Zhang Q; Li J; Duan P
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29669843
[TBL] [Abstract][Full Text] [Related]
19. Studies of Correlations Between Single Nucleotide Polymorphisms of DNA Repair Genes and Endometrial Cancer in Polish Women.
Smolarz B; Michalska MM; Samulak D; Wójcik L; Romanowicz H
Anticancer Res; 2018 Sep; 38(9):5223-5229. PubMed ID: 30194171
[TBL] [Abstract][Full Text] [Related]
20. Common gene variants in RAD51, XRCC2 and XPD are not associated with clinical outcome in soft-tissue sarcoma patients.
Szkandera J; Absenger G; Liegl-Atzwanger B; Pichler M; Stotz M; Gerger S; Zacherl M; Renner W; Haijun M; Leithner A; Gerger A
Cancer Epidemiol; 2013 Dec; 37(6):1003-9. PubMed ID: 24189466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]